Arsenic and Diabetes: Navas-Acien et al. Respond
Ana Navas-Acien1, Elizabeth A. Maull2, Kristina A. Thayer2
1Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; 2Division of the National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, North Carolina, E-mail: firstname.lastname@example.org
Environ Health Perspect 121:a71–a72 (2013). http://dx.doi.org/10.1289/ehp.1206100R [Online 1 March 2013]
The author declares they have no actual or potential competing financial interests.
The goal of the National Toxicology Program (NTP) workshop review was to comprehensively evaluate the association between arsenic and diabetes, including epidemiologic and experimental evidence (Maull et al. 2012). Members of the arsenic breakout group carefully evaluated differences in methodologic approaches used to analyze general population studies, including NHANES (National Health Nutrition and Examination Survey) studies, trying to understand the biology and technical limitations of biomarkers of inorganic arsenic exposure measured in urine, as well as their implications for study findings.
In his letter, Smith presents his arguments in a selective manner, overlooking important evidence and facts. First, multiple studies included in the NTP workshop review [see our Table 2 (Maull et al. 2012)] support the relationship of low-to-moderate arsenic exposure levels (< 150 µg/L in drinking water) with diabetes and diabetes-related end points. Second, when indicating that subtracting arsenobetaine from total arsenic is the recommended method to evaluate inorganic arsenic exposure, Smith ignored research conducted in the last decade showing that other seafood arsenicals (arsenosugars, arsenolipids) also contribute to total urinary arsenic (European Food Safety Authority 2009; Francesconi et al. 2002; Maull et al. 2012). Subtracting arsenobetaine from total arsenic is insufficient to eliminate the contribution of seafood arsenicals in populations where seafood is common (see Figure 1 of Maull et al. 2012). Third, Smith criticized the adjustment of the association between total urinary arsenic and diabetes for arsenobetaine without mentioning that total urinary arsenic was associated with diabetes without adjusting for arsenobetaine in NHANES participants with very low or undetectable arsenobetaine (Navas-Acien et al. 2008, 2009), populations where total urinary arsenic likely reflects inorganic arsenic exposure. These results at low arsenobetaine concentrations exclude collinearity as an explanation for the findings. The consistency between analyses that are restricted to very low arsenobetaine concentrations and analyses that statistically adjust for arsenobetaine is not a surprise because both epidemiologic strategies are able to minimize the contribution of other seafood arsenicals to total urine arsenic concentrations. In a transparent manner, the NTP workshop review acknowledged the differing interpretations of the NHANES studies, concluding that the lack of consistency… warrants caution in interpreting results and highlights the importance of having good analytical methods to distinguish inorganic arsenic.
As summarized in our NTP workshop review (Maull et al. 2012), the evidence is currently insufficient to conclude that arsenic is associated with diabetes at low-to-moderate exposure levels. Limitations of many of the available studies included the lack of prospective evidence, limitations in exposure and outcome assessment, and lack of adjustment for appropriate confounders. Since the publication of the NTP workshop review, additional cross-sectional (Gribble et al. 2012) and prospective (James et al. 2012; Kim et al., in press) studies conducted in the United States and supporting the association between arsenic and diabetes have been published.
Millions of Americans are exposed to arsenic through drinking water and food. Smith recommended that arsenic research focus on levels in drinking water that are 15 times higher than the current safety standards of the World Health Organization, U.S. Environmental Protection Agency, and European Union. In our opinion, research and public health efforts should focus on preventing arsenic exposure. At low-to-moderate levels, state-of-the-art epidemiologic tools—including cost-effective designs, high quality exposure and outcome assessment, careful evaluation of dose–response relationships, and integrated methods to evaluate gene–environment interactions and mechanistic pathways—can provide insight into the health effects of arsenic exposure through drinking water and food.
European Food Safety Authority. 2009. Scientific Opinion on Arsenic in Food: EFSA Panel on Contaminants in the Food Chain (CONTAM). EFSA J 7(10):1351. Available: http://www.efsa.europa.eu/en/scdocs/scdoc/1351.htm [accessed 12 December 2011].
Francesconi KA, Tanggaar R, McKenzie CJ, Goessler W. 2002. Arsenic metabolites in human urine after ingestion of an arsenosugar. Clin Chem 48(1):92–101.
Gribble MO, Howard BV, Umans JG, Shara NM, Francesconi KA, Goessler W, et al. 2012. Arsenic exposure, diabetes prevalence, and diabetes control in the Strong Heart Study. Am J Epidemiol 176(10):865–874.
James KA, Marshall JA, Hokanson JE, Meliker JR, Zerbe GO, Byers T. 2012. Lifetime exposure to inorganic arsenic in drinking water and diabetes mellitus [Abstract]. E-010. Epidemiology 23(5S); doi: 10.1097/01.ede.0000416610.83368.a7.
Kim N, Mason C, Nelson R, Afton S, Essader A, Medlin J, et al. In press. Arsenic exposure and incidence of type 2 diabetes in Southwestern American Indians. Am J Epidemiol.
Maull EA, Ahsan H, Edwards J, Longnecker MP, Navas-Acien A, Pi J, et al. 2012. Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review. Environ Health Perspect 120:1658–1670.
Navas-Acien A, Silbergeld EK, Pastor-Barriuso R, Guallar E. 2008. Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA 300(7):814–822.
Navas-Acien A, Silbergeld EK, Pastor-Barriuso R, Guallar E. 2009. Rejoinder: Arsenic exposure and prevalence of type 2 diabetes: updated findings from the National Health Nutrition and Examination Survey, 2003–2006. Epidemiology 20(6):816–820.
Sign Up to Receive E-mail Alerts
Recent Advance Publications
- Ambient Air Pollution and Depressive Symptoms in Older Adults: Results from the MOBILIZE Boston Study
- The Human Early-Life Exposome (HELIX): Project Rationale and Design
- Epigenetic Influences on Associations between Air Pollutants and Lung Function in Elderly Men: The Normative Aging Study
- Associations between Traffic Noise, Particulate Air Pollution, Hypertension, and Isolated Systolic Hypertension in Adults: The KORA Study
- Estimating the Health Effects of Greenhouse Gas Mitigation Strategies: Addressing Parametric, Model, and Valuation Challenges
- Environmental Burden of Disease in Europe: Assessing Nine Risk Factors in Six Countries
- Non-Renal Effects and the Risk Assessment of Environmental Cadmium Exposure
- Trending EHP news this week: Chemicals in feminine hygiene products, personal lubricants http://t.co/RKLD6E7IKv
- Trending EHP research this week: Most plastic products release estrogenic chemicals http://t.co/YjnVQqflLu
- AdvPubl: Ambient air pollution and depressive symptoms in older adults: results from the MOBILIZE Boston study http://t.co/QJXO7WXjlM
- AdvPubl: The Human Early-Life Exposome (HELIX): project rationale and design http://t.co/T4UHBDeXvT
- CareerOpp: Tenure track non-clinical prof/assoc prof/asst/prof, environmental health, Sch Public Health, U Hong Kong http://t.co/9ZFkq4k4ST